Alkem Foundation, IIT Bombay to Set Up Advanced Research Centre

05 Nov 2025 CW Team

Under this partnership, Alkem Foundation will fund the creation of the Alkem Centre for Advanced Research and Development of Applied Immuno-Therapeutics and Regenerative Medicines within the IIT Bombay campus. The foundation will contribute around 20–25 per cent of its cumulative CSR obligations over seven years towards this project.

The initiative marks India’s first industry–academia collaboration, initiated through the CSR route, to promote advanced research in these complex therapeutic areas. It will combine Alkem’s experience in developing pharmaceutical solutions with IIT Bombay’s expertise in biomedical engineering, biosciences, and translational research to create an innovation-driven ecosystem.

The centre aims to build a holistic platform for research, innovation, and skill development in high-precision and underserved therapy areas, bridging gaps in infrastructure, talent, and translational capability. It will also align with IIT Bombay’s multidisciplinary healthcare approach that integrates biology, engineering, and data science to advance human health.

Future research will explore frontier domains such as gene editing, biomaterials, and delivery technologies for immuno-therapeutics and regenerative medicine. The centre will serve as a hub for clinician-scientists and biotech entrepreneurs, supported by IIT Bombay faculty, Alkem mentors, and global experts from leading universities.

Madhurima Singh, Executive Director and Chairperson, CSR and Sustainability Committee, Alkem, said, “We believe in going beyond business to support R&D in areas of significant medical need. Our partnership with IIT Bombay reflects a shared commitment to fostering innovation and developing advanced, affordable treatments that can enhance both lifespan and quality of life.”

Prof. Shireesh B. Kedare, Director, IIT Bombay, added, “This collaboration will accelerate translation of cutting-edge research into real-world healthcare impact, helping India achieve self-reliance in biomedical innovation.”

Mumbai, November 3, 2025 — Alkem Foundation, the Corporate Social Responsibility (CSR) arm of Alkem Laboratories, has announced a strategic collaboration with the Indian Institute of Technology Bombay (IIT Bombay) to establish a first-of-its-kind research centre in India dedicated to immuno-therapeutics and regenerative medicines. Under this partnership, Alkem Foundation will fund the creation of the Alkem Centre for Advanced Research and Development of Applied Immuno-Therapeutics and Regenerative Medicines within the IIT Bombay campus. The foundation will contribute around 20–25 per cent of its cumulative CSR obligations over seven years towards this project. The initiative marks India’s first industry–academia collaboration, initiated through the CSR route, to promote advanced research in these complex therapeutic areas. It will combine Alkem’s experience in developing pharmaceutical solutions with IIT Bombay’s expertise in biomedical engineering, biosciences, and translational research to create an innovation-driven ecosystem. The centre aims to build a holistic platform for research, innovation, and skill development in high-precision and underserved therapy areas, bridging gaps in infrastructure, talent, and translational capability. It will also align with IIT Bombay’s multidisciplinary healthcare approach that integrates biology, engineering, and data science to advance human health. Future research will explore frontier domains such as gene editing, biomaterials, and delivery technologies for immuno-therapeutics and regenerative medicine. The centre will serve as a hub for clinician-scientists and biotech entrepreneurs, supported by IIT Bombay faculty, Alkem mentors, and global experts from leading universities. Madhurima Singh, Executive Director and Chairperson, CSR and Sustainability Committee, Alkem, said, “We believe in going beyond business to support R&D in areas of significant medical need. Our partnership with IIT Bombay reflects a shared commitment to fostering innovation and developing advanced, affordable treatments that can enhance both lifespan and quality of life.” Prof. Shireesh B. Kedare, Director, IIT Bombay, added, “This collaboration will accelerate translation of cutting-edge research into real-world healthcare impact, helping India achieve self-reliance in biomedical innovation.”

Equipment

03 Jun 2026

John Crane Retrofit Cuts Water Use at Copper Mine Pump

John Crane has retrofitted a mechanical seal on a large underflow thickener slurry pump at a major copper mining operation, reducing sealing water consumption by around 288,000 litres per day while improving maintenance efficiency on a critical asset.The retrofit replaced the pump's traditional stuffing box arrangement, which required shaft sleeve replacement every four months due to abrasive wear. These maintenance activities involved significant downtime, a 100-tonne crane and extensive manpower.John Crane developed a mechanical seal package that could be installed without modifying the exis..

Resources

03 Jun 2026

TKIL Industries Appoints Gaurav Srivastava as CFO

TKIL Industries has appointed Gaurav Kumar Srivastava as Chief Financial Officer (CFO), effective 1 June 2026. He succeeds Ketan Pendse, Chief Financial Officer and Whole-time Director, who is stepping down after more than two decades with the company. Srivastava previously served as Executive Vice President, Finance & Taxation.Announcing the appointment, Vivek Bhatia, Managing Director & CEO, TKIL Industries, thanked Pendse for his long-standing contribution to the organisation and wished him success in his future endeavours.Bhatia said, “Gaurav’s appointment reflects our continued focus ..

Technology

03 Jun 2026

Siemens Launches Intelligence Center X for AI

Siemens has launched Intelligence Center X, an industrial AI orchestration software designed to help organisations move from isolated AI pilots to scalable business impact. The software enables people and AI agents to work together through shared context, workflows and lifecycle intelligence.Part of Siemens Xcelerator, Intelligence Center X connects industrial data, models and workflows on a governed foundation, allowing companies to deploy AI-driven applications and agents with traceability and control. It combines the Mendix low-code platform with Siemens’ Graph Studio and AI Studio softwa..